BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29920623)

  • 21. Synergy of theophylline reduces necrotic effect of berberine, induces cell cycle arrest and PARP, HMGB1, Bcl-2 family mediated apoptosis in MDA-MB-231 breast cancer cells.
    Hashemi-Niasari F; Rabbani-Chadegani A; Razmi M; Fallah S
    Biomed Pharmacother; 2018 Oct; 106():858-867. PubMed ID: 30119256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptomic insight into salinomycin mechanisms in breast cancer cell lines: synergistic effects with dasatinib and induction of estrogen receptor β.
    Bellat V; Verchère A; Ashe SA; Law B
    BMC Cancer; 2020 Jul; 20(1):661. PubMed ID: 32678032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination treatment with dendrosomal nanocurcumin and doxorubicin improves anticancer effects on breast cancer cells through modulating CXCR4/NF-κB/Smo regulatory network.
    Mahjoub MA; Bakhshinejad B; Sadeghizadeh M; Babashah S
    Mol Biol Rep; 2017 Aug; 44(4):341-351. PubMed ID: 28752270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclin D1 overexpression and response to bortezomib treatment in a breast cancer model.
    Ishii Y; Pirkmaier A; Alvarez JV; Frank DA; Keselman I; Logothetis D; Mandeli J; O'Connell MJ; Waxman S; Germain D
    J Natl Cancer Inst; 2006 Sep; 98(17):1238-47. PubMed ID: 16954476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-tumor activities of luteolin and silibinin in glioblastoma cells: overexpression of miR-7-1-3p augmented luteolin and silibinin to inhibit autophagy and induce apoptosis in glioblastoma in vivo.
    Chakrabarti M; Ray SK
    Apoptosis; 2016 Mar; 21(3):312-28. PubMed ID: 26573275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-delivery of artemisinin and metformin via PEGylated niosomal nanoparticles: potential anti-cancer effect in treatment of lung cancer cells.
    Abdulkareem SJ; Jafari-Gharabaghlou D; Farhoudi-Sefidan-Jadid M; Salmani-Javan E; Toroghi F; Zarghami N
    Daru; 2024 Jun; 32(1):133-144. PubMed ID: 38168007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic-based combinatorial resveratrol and pterostilbene alters DNA damage response by affecting SIRT1 and DNMT enzyme expression, including SIRT1-dependent γ-H2AX and telomerase regulation in triple-negative breast cancer.
    Kala R; Shah HN; Martin SL; Tollefsbol TO
    BMC Cancer; 2015 Oct; 15():672. PubMed ID: 26459286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line.
    Duo J; Ma Y; Wang G; Han X; Zhang C
    DNA Cell Biol; 2013 Apr; 32(4):156-64. PubMed ID: 23451817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
    Liu H; Zang C; Emde A; Planas-Silva MD; Rosche M; Kühnl A; Schulz CO; Elstner E; Possinger K; Eucker J
    Eur J Pharmacol; 2008 Sep; 591(1-3):43-51. PubMed ID: 18588872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tangeretin boosts the anticancer activity of metformin in breast cancer cells via curbing the energy production.
    Mdkhana B; Zaher DM; Abdin SM; Omar HA
    Phytomedicine; 2021 Mar; 83():153470. PubMed ID: 33524703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin E analog alpha-TEA, methylseleninic acid, and trans-resveratrol in combination synergistically inhibit human breast cancer cell growth.
    Snyder RM; Yu W; Jia L; Sanders BG; Kline K
    Nutr Cancer; 2008; 60(3):401-11. PubMed ID: 18444175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth inhibitory and adjuvant therapeutic potential of aqueous extract of Triticum aestivum on MCF-7 and HeLa cells.
    Hussain A; Gheewala TM; Vas AJ; Shah K; Goala P; Khan S; Hinduja S; Sharma C
    Exp Oncol; 2014 Mar; 36(1):9-16. PubMed ID: 24691278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pterostilbene down-regulates hTERT at physiological concentrations in breast cancer cells: Potentially through the inhibition of cMyc.
    Daniel M; Tollefsbol TO
    J Cell Biochem; 2018 Apr; 119(4):3326-3337. PubMed ID: 29125889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fabricating niosomal-PEG nanoparticles co-loaded with metformin and silibinin for effective treatment of human lung cancer cells.
    Salmani-Javan E; Jafari-Gharabaghlou D; Bonabi E; Zarghami N
    Front Oncol; 2023; 13():1193708. PubMed ID: 37664043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of metformin on proliferation of human colon carcinoma cell line SW-480].
    Zhou XZ; Xue YM; Zhu B; Sha JP
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Aug; 30(8):1935-8, 1942. PubMed ID: 20813708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of metformin and valproic acid synergistically induces cell cycle arrest and apoptosis in clear cell renal cell carcinoma.
    Zhang X; Zhang X; Huang T; Geng J; Liu M; Zheng J
    Int J Clin Exp Pathol; 2015; 8(3):2823-8. PubMed ID: 26045790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Berberine and Evodiamine Act Synergistically Against Human Breast Cancer MCF-7 Cells by Inducing Cell Cycle Arrest and Apoptosis.
    Du J; Sun Y; Lu YY; Lau E; Zhao M; Zhou QM; Su SB
    Anticancer Res; 2017 Nov; 37(11):6141-6151. PubMed ID: 29061795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin potentiates anti-tumor effect of resveratrol on pancreatic cancer by down-regulation of VEGF-B signaling pathway.
    Zhu M; Zhang Q; Wang X; Kang L; Yang Y; Liu Y; Yang L; Li J; Yang L; Liu J; Li Y; Zu L; Shen Y; Qi Z
    Oncotarget; 2016 Dec; 7(51):84190-84200. PubMed ID: 27705937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin combined with quercetin synergistically repressed prostate cancer cells via inhibition of VEGF/PI3K/Akt signaling pathway.
    Sun S; Gong F; Liu P; Miao Q
    Gene; 2018 Jul; 664():50-57. PubMed ID: 29678660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trastuzumab enhances the anti-tumor effects of the histone deacetylase inhibitor sodium butyrate on a HER2-overexpressing breast cancer cell line.
    Chen W; Wei F; Xu J; Wang Y; Chen L; Wang J; Guan X
    Int J Mol Med; 2011 Dec; 28(6):985-91. PubMed ID: 21887460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.